Table 5.
Group No. | Treatment | Upper Pole | Mid Pole | Lower Pole | Average |
---|---|---|---|---|---|
B | EG | 111.83 | 92.67 | 105.33 | 119.33 |
C | EG + low drug | 5 | 4.67 | 2 | 2.33 * |
D | EG + high drug | 14 | 7.5 | 15 | 12.17 * |
Group B: No. 7–12 (control: 0.4% of EG); Group C: No. 13–18 (EG + low dose drug for 2 weeks) *; Group D: No. 19–24 (EG + high dose drug for 2 weeks) *; The p values of mark [*] was less than 0.001.